Cure8 research brief
Knowing which symptoms and non-invasive biomarkers most strongly associate with UC can help patients and clinicians decide who should be prioritized for diagnostic endoscopy and for monitoring disease activity.
Adults with suspected or diagnosed ulcerative colitis, clinicians who evaluate or triage patients with possible IBD, and researchers studying IBD biomarkers or diagnostic pathways.
This is a systematic review and meta-analysis (389 studies) summarizing clinical features and non-invasive laboratory biomarkers associated with ulcerative colitis (UC).
The authors report strong associations for symptoms such as bloody mucopurulent stools and tenesmus with UC, and highlight fecal calprotectin, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) as significantly associated with UC activity and differential risk.
The article frames these associations as useful for prioritizing patients for invasive endoscopy. The paper appears to be an evidence synthesis (World Journal of Gastroenterology, in press) and is open access.
Because this is a meta-analysis, it aggregates existing studies rather than reporting a new trial; readers should view the findings as pooled associations rather than causal effects. The summary here is grounded in the article metadata and the provided abstract-like core tip.
This work is a meta-analysis pooling many studies; results reflect associations across heterogeneous study designs and populations. The article is in press in World Journal of Gastroenterology and open access. Meta-analytic associations do not establish causation and clinical decisions should integrate individual patient context and current guidelines.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
A wearable sensor that reliably measures inflammation markers (CRP and calprotectin) from sweat could make inflammation monitoring less invasive and more frequent for people with IBD, potentially helping detect flares...
The T&W criteria are still used to define severe UC on admission, but relying on them alone may delay recognition of steroid non‑response and escalation decisions. Integrating biomarkers, endoscopy, and imaging can help...
Noninvasive blood biomarkers that track IBD activity could reduce reliance on repeat endoscopy. If validated, serum galectin‑3 might complement fecal calprotectin and CRP to help identify active disease.
